Characterization of heparin oligosaccharides binding specifically to antithrombin III using mass spectrometry

Biochemistry

Volumn 47, Issue 10, 2008, Pages 3155-3161

  Naimy, Hicham ^a   Leymarie, Nancy ^a   Bowman, Michael J ^a   Zaia, Joseph ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING SITES; CELL PROLIFERATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PROTEINS;

BLOOD COAGULATION; HEPARAN SULFATE (HS); PROTEIN BINDING;

OLIGOSACCHARIDES;

ANTITHROMBIN III; BLOOD CLOTTING FACTOR 10A; HEPARIN DERIVATIVE; OLIGOSACCHARIDE;

ARTICLE; HYDROPHOBICITY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; QUANTITATIVE ANALYSIS; REPRODUCIBILITY;

ANIMALS; ANTITHROMBIN III; CHROMATOGRAPHY, LIQUID; HEPARIN; HYDROPHOBICITY; OLIGOSACCHARIDES; PROTEIN BINDING; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SWINE;

EID: 40549123949     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi702043e     Document Type: Article

References (58)

1. Lindahl, U., and Roden, L. (1964) The linkage of heparin to protein. Biochem. Biophys. Res. Commun. 17, 254-259.
2. Lindahl, U., and Roden, L. (1965) The Role of Galactose and Xylose in the Linkage of Heparin to Protein. J. Biol. Chem. 240, 2821-2826.
3. Lindahl, U., Cifonelli, J. A., Lindahl, B., and Roden, L. (1965) The Role of Serine in the Linkage of Heparin to Protein. J. Biol. Chem. 240, 2817-2820.
4. Forsee, W. T., and Roden, L. (1981) Biosynthesis of heparin. Transfer of N-acetylglucosamine to heparan sulfate oligosaccharides. J. Biol. Chem. 256, 7240-7247.
5. Lind, T., Lindahl, U., and Lidholt, K. (1993) Biosynthesis of heparin/heparan sulfate. Identification of a 70 kDa protein catalyzing both the D-glucuronosyl- and the N-acetyl-D-glucosaminyl-transferase reactions. J. Biol. Chem. 268, 20705-20708.
6. Navia, J. L., Riesenfeld, J., Vann, W. F., Lindahl, U., and Roden, L. (1983) Assay of N-acetylheparosan deacetylase with a capsular polysaccharide from Escherichia coli K5 as substrate. Anal. Biochem. 135, 134-140.
7. Lindahl, U., Backstrom, G., Jansson, L., and Hallen, A. (1973) Biosynthesis of heparin. II. Formation of sulfamino groups. J. Biol. Chem. 248, 7234-7241.
8. Riesenfeld, J., Hook, M., and Lindahl, U. (1980) Biosynthesis of heparin. Assay and properties of the microsomal N-acetyl-D-glucosaminyl N-deacetylase. J. Biol. Chem. 255, 922-928.
9. Riesenfeld, J., Hook, M., and Lindahl, U. (1982) Biosynthesis of heparin. Concerted action of early polymer-modification reactions. J. Biol. Chem. 257, 421-425.
10. Kusche, M., Hannesson, H. H., and Lindahl, U. (1991) Biosynthesis of heparin. Use of Escherichia coli K5 capsular polysaccharide as a model substrate in enzymic polymer-modification reactions. Biochem. J. 275, 151-158.
11. Bame, K. J., Reddy, R. V., and Esko, J. D. (1991) Coupling of N-deacetylation and N-sulfation in a Chinese hamster ovary cell mutant defective in heparan sulfate N-sulfotransferase. J. Biol. Chem. 266, 12461-12468.
12. Lidholt, K., and Lindahl, U. (1992) Biosynthesis of heparin. The D-glucuronosyl- and N-acetyl-D-glucosaminyltransferase reactions and their relation to polymer modification. Biochem. J. 287, 21-29.
13. Lindahl, U., Backstrom, G., Malmstrom, A., and Fransson, L. A. (1972) Biosynthesis of L-iduronic acid in heparin: Epimerization of D-glucuronic acid on the polymer level. Biochem. Biophys. Res. Commun. 46, 985-991.
14. Hook, M., Lindahl, U., Backstrom, G., Malmstrom, A., and Fransson, L. (1974) Biosynthesis of heparin. 3. Formation of iduronic acid residues. J. Biol. Chem. 249, 3908-3915.
15. Malmstrom, A., Roden, L., Feingold, D. S., Jacobsson, I., Backstrom, G., and Lindahl, U. (1980) Biosynthesis of heparin. Partial purification of the uronosyl C-5 epimerase. J. Biol. Chem. 255, 3878-3883.
16. Kusche, M., and Lindahl, U. (1990) Biosynthesis of heparin. O-Sulfation of D-glucuronic acid units. J. Biol. Chem. 265, 15403-15409.
17. Jacobsson, I., and Lindahl, U. (1980) Biosynthesis of heparin. Concerted action of late polymer-modification reactions. J. Biol. Chem. 255, 5094-5100.
18. Esko, J. D., and Selleck, S. B. (2002) Order out of chaos: Assembly of ligand binding sites in heparan sulfate. Annu. Rev. Biochem. 71, 435-471.
19. Varki, A., Cummings, R., Esko, J., Freeze, H., Hart, G., and Marth, G. (1999) Essentials of Glycobiology, Cold Spring Harbor Laboratory Press, Plainview, NY.
20. Conrad, H. E. (1998) Heparin Binding Proteins, Academic Press, New York.
21. Capila, I., and Linhardt, R. J. (2002) Heparin-protein interactions. Angew. Chem., Int. Ed. 41, 391-412.
22. Goldsmith, E. J., and Mottonen, J. (1994) Serpins: The uncut version. Structure 2, 241-244.
23. Damus, P. S., Hicks, M., and Rosenberg, R. D. (1973) Anticoagulant action of heparin. Nature 246, 355-357.
24. Bjork, I., Ylinenjarvi, K., Olson, S. T., and Bock, P. E. (1992) Conversion of antithrombin from an inhibitor of thrombin to a substrate with reduced heparin affinity and enhanced conformational stability by binding of a tetradecapeptide corresponding to the P1 to P14 region of the putative reactive bond loop of the inhibitor. J. Biol. Chem. 267, 1976-1982.
25. Villanueva, G., and Danishefsky, I. (1979) Conformational changes accompanying the binding of antithrombin III to thrombin. Biochemistry 18, 810-817.
26. Lindahl, U., Thunberg, L., Backstrom, G., Riesenfeld, J., Nordling, K., and Bjork, I. (1984) Extension and structural variability of the antithrombin-binding sequence in heparin. J. Biol. Chem. 259, 12368-12376.
27. 13C nuclear-magnetic-resonance studies. Biochem. J. 197, 599-609.
28. Thunberg, L., Backstrom, G., and Lindahl, U. (1982) Further characterization of the antithrombin-binding sequence in heparin. Carbohydr. Res. 100, 393-410.
29. Atha, D. H., Stephens, A. W., Rimon, A., and Rosenberg, R. D. (1984) Sequence variation in heparin octasaccharides with high affinity for antithrombin III. Biochemistry 23, 5801-5812.
30. Atha, D. H., Lormeau, J. C., Petitou, M., Rosenberg, R. D., and Choay, J. (1985) Contribution of monosaccharide residues in heparin binding to antithrombin III. Biochemistry 24, 6723-6729.
31. Riesenfeld, J., Thunberg, L., Hook, M., and Lindahl, U. (1981) The antithrombin-binding sequence of heparin. Location of essential N-sulfate groups. J. Biol. Chem. 256, 2389-2394.
32. Lindahl, U., Backstrom, G., and Thunberg, L. (1983) The antithrombin-binding sequence in heparin. Identification of an essential 6-O-sulfate group. J. Biol. Chem. 258, 9826-9830.
33. Lindahl, U., Backstrom, G., Thunberg, L., and Leder, I. G. (1980) Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin. Proc. Natl. Acad. Sci. U.S.A. 77, 6551-6555.
34. Petitou, M., Duchaussoy, P., Lederman, I., Choay, J., and Sinay, P. (1988) Binding of heparin to antithrombin III: A chemical proof of the critical role played by a 3-sulfated 2-amino-2-deoxy-D-glucose residue. Carbohydr. Res. 179, 163-172.
35. Maccarana, M., Casu, B., and Lindahl, U. (1993) Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor. J. Biol. Chem. 268, 23898-23905.
36. Kreuger, J., Prydz, K., Pettersson, R. F., Lindahl, U., and Salmivirta, M. (1999) Characterization of fibroblast growth factor 1 binding heparan sulfate domain. Glycobiology 9, 723-729.
37. Turnbull, J. E., Hopwood, J. J., and Gallagher, J. T. (1999) A strategy for rapid sequencing of heparan sulfate and heparin saccharides. Proc. Natl. Acad. Sci. U.S.A. 96, 2698-2703.
38. Venkataraman, G., Shriver, Z., Raman, R., and Sasisekharan, R. (1999) Sequencing complex polysaccharides. Science 286, 537-542.
39. Vives, R. R., Pye, D. A., Salmivirta, M., Hopwood, J. J., Lindahl, U., and Gallagher, J. T. (1999) Sequence analysis of heparan sulphate and heparin oligosaccharides. Biochem. J. 339, 767-773.
40. Loganathan, D., Wang, H. M., Mallis, L. M., and Linhardt, R. J. (1990) Structural variation in the antithrombin III binding site region and its occurrence in heparin from different sources. Biochemistry 29, 4362-4368.
41. Pervin, A., Gallo, C., Jandik, K. A., Han, X. J., and Linhardt, R. J. (1995) Preparation and structural characterization of large heparin-derived oligosaccharides. Glycobiology 5, 83-95.
42. Kuberan, B., Lech, M., Zhang, L., Wu, Z. L., Beeler, D. L., and Rosenberg, R. D. (2002) Analysis of heparan sulfate oligosaccharides with ion pair-reverse phase capillary high performance liquid chromatography- microelectrospray ionization time-of-flight mass spectrometry. J. Am. Chem. Soc. 124, 8707-8718.
43. Lawrence, R., Kuberan, B., Lech, M., Beeler, D. L., and Rosenberg, R. D. (2004) Mapping critical biological motifs and biosynthetic pathways of heparan sulfate. Glycobiology 14, 467-479.
44. Ziegler, A., and Zaia, J. (2006) Size-exclusion chromatography of heparin oligosaccharides at high and low pressure. J. Chromatogr. 837, 76-86.
45. Harmer, N. J., Robinson, C. J., Adam, L. E., Ilag, L. L., Robinson, C. V., Gallagher, J. T., and Blundell, T. L. (2006) Multimers of the fibroblast growth factor (FGF)-FGF receptor-saccharide complex are formed on long oligomers of heparin. Biochem. J. 393, 741-748.
46. Yu, Y., Sweeney, M. D., Saad, O. M., Crown, S. E., Hsu, A. R., Handel, T. M., and Leary, J. A. (2005) Chemokine-glycosaminoglycan binding: Specificity for CCR2 ligand binding to highly sulfated oligosaccharides using FTICR mass spectrometry. J. Biol. Chem. 280, 32200-32208.
47. Sweeney, M. D., Yu, Y., and Leary, J. A. (2006) Effects of sulfate position on heparin octasaccharide binding to CCL2 examined by tandem mass spectrometry. J. Am. Soc. Mass Spectrom. 17, 1114-1119.
48. Schenauer, M. R., Yu, Y., Sweeney, M. D., and Leary, J. A. (2008) CCR2 chemokines bind selectively to acetylated heparan sulfate octasaccharides. J. Biol. Chem. (in press).
49. Alpert, A. J., Shukla, M., Shukla, A. K., Zieske, L. R., Yuen, S. W., Ferguson, M. A., Mehlert, A., Pauly, M., and Orlando, R. (1994) Hydrophilic-interaction chromatography of complex carbohydrates. J. Chromatogr., A 676, 191-222.
50. Akiyama, H., Shidawara, S., Mada, A., Toyoda, H., Toida, T., and Imanari, T. (1992) Chemiluminescence high-performance liquid chromatography for the determination of hyaluronic acid, chondroitin sulphate and dermatan sulphate. J. Chromatogr. 579, 203-207.
51. Hitchcock, A. M., Yates, K. E., Costello, C. E., and Zaia, J. (2008) Comparative glycomics of connective tissue glycosaminoglycans. J. Biol. Chem. (submitted for publication).
52. Wuhrer, M., Koeleman, C. A., Deelder, A. M., and Hokke, C. H. (2004) Normal-phase nanoscale liquid chromatography-mass spectrometry of underivatized oligosaccharides at low-femtomole sensitivity. Anal. Chem. 76, 833-838.
53. Wuhrer, M., Koeleman, C. A., Hokke, C. H., and Deelder, A. M. (2005) Protein glycosylation analyzed by normal-phase nano-liquid chromatography-mass spectrometry of glycopeptides. Anal. Chem. 77, 886-894.
54. Bowman, M. J., C. E. C., Hitchcock, A. M., Lau, J. M., Leymarie, N., Miller, C., Naimy, H., Shi, X., Staples, G. O., and Zaia, J. (2008) A chip-based Amide-HILIC LC/MS Platform for Glycosaminoglycan Glycomics, manuscript in preparation.
55. Likhosherstov, L. M., Novikova, O. S., Derevitskaja, V. A., and Kochetkov, N. K. (1986) A New Simple Synthesis of Amino Sugar β-D-Glycosylamines. Carbohydr. Res. 146, C1-C5.
56. Manger, I. D., Rademacher, T. W., and Dwek, R. A. (1992) 1-N-Glycyl β-oligosaccharide derivatives as stable intermediates for the formation of glycoconjugate probes. Biochemistry 31, 10724-10732.
57. Petitou, M., Lormeau, J. C., and Choay, J. (1991) Chemical synthesis of glycosaminoglycans: New approaches to antithrombotic drugs. Nature 350, 30-33.
58. Abzalimov, R. R., Dubin, P. L., and Kaltashov, I. A. (2007) Glycosaminoglycans as naturally occurring combinatorial libraries: Developing a mass spectrometry-based strategy for characterization of anti-thrombin interaction with low molecular weight heparin and heparin oligomers. Anal. Chem. 79, 6055-6063.